Welcome to RNAiScience
This website is created for US healthcare professionals to provide access to educational, clinical, and scientific information about Alnylam's therapeutic areas and the science of RNAi behind our FDA-approved therapies and clinical pipeline. Explore the site or connect with us to learn more about our science.
Search for educational content on Disease & Therapeutic Areas and Alnylam Therapies
- Use the "Search" feature to discover Disease & Therapeutic Area educational content based on key terms
- More than one search term is recommended to yield the most relevant results
- By searching, you confirm that your query is unsolicited
We’re sorry, no results were found for your search: Hypertnghy
For further information regarding your request, please connect with us
by reaching out to our Medical Information team.
Search Congress and Publication resources
- Use the "Search" feature to discover Congresses & Publications resources based on key terms
- More than one search term is recommended to yield the most relevant results
- By searching, you confirm that your query is unsolicited
Search for educational content on Disease & Therapeutic Areas and Alnylam Therapies
- Use the "Search" feature to discover Disease & Therapeutic Area educational content based on key terms
- More than one search term is recommended to yield the most relevant results
- By searching, you confirm that your query is unsolicited
We’re sorry, no results were found for your search: Hypertnghy
For further information regarding your request, please connect with us
by reaching out to our Medical Information team.
Search Congress and Publication resources
- Use the "Search" feature to discover Congresses & Publications resources based on key terms
- More than one search term is recommended to yield the most relevant results
- By searching, you confirm that your query is unsolicited
Disease & Therapeutic Areas
Select below to explore educational materials by Disease & Therapeutic Area
Science of RNAi
RNAi Mechanism of Action
This video highlights the mechanism of action (MOA) of RNAi therapeutics and its role in silencing gene expression. This video is intended to be viewed in its entirety.
News & Latest Resources
ATTRv Amyloidosis Hub
This Resource Center, provided by PRIME Education and supported by Alnylam Pharmaceuticals, contains downloadable resources and practical tools to support coordinated, multidisciplinary care and facilitate timely, comprehensive diagnostic evaluations for patients with ATTRv (also known as hATTR) amyloidosis.
Keywords: amyloidosis, ATTRv, diagnosis, hATTR
Our Therapies
Explore a breadth of educational, scientific, and clinical resources related to the FDA-approved uses of our therapies.
Pipeline
Discover our pipeline of RNAi-based therapies. Learn more about these therapeutics, including clinical trial information.
Connect with Alnylam Medical
For further information about Alnylam's FDA-approved therapies, clinical pipeline, and therapeutic areas of interest, connect with Alnylam Medical below
Medical Information
For Medical Information inquiries, please call or email:
Adverse Events/Product Complaints
To report an adverse event or to make a product complaint, please call or email:
Clinical Trials
For clinical trial inquiries, please use the contact options below:
Medical Science Liaison (MSL) Locator
Enter the required information here to locate your region's Medical Science Liaison (MSL)
